Background
In most published studies, pain perception has been reported to be higher for females with Fibromyalgia Syndrome (FMS). However, males have and continue to suffer with significant pain, debility, and functional decline.
Objective
To examine sex-based differences in symptomatology and disease impact in patients with FMS.
Design
Questionnaires distributed to patients from between December 2022, and February 2023.
Setting
The FMS unit of the Hospital Santa Maria de Lleida, Spain
Main Outcome Measures
We measured sociodemographic and clinical variables, including comorbidities, ongoing treatment strategies, and the Fibromyalgia Impact Questionnaire (FIQ).
Results
Participants were 50 males and 50 females. Males were older (M = 58, SD = 9.77) than females (M = 50, SD = 14.51). Females were younger, more often single, and had higher unemployment and obesity rates. Males had lower educational status and received more support from parents and children. Males experienced more sleep problems, napping/sleeping during the day and sleeping poorly at night. Furthermore, males used more opioids.
There were no differences in the FIQ subscale of physical impairment in the activities of daily living (ADLs). However, greater disability was reported in making the bed and preparing meals among females, while males had more difficulties with yard work and driving. Males felt unwell more days than females.
Conclusion
Overweight, medicinal plant use, massage, and music therapy were more significant in females, whereas paternal and filial support and opioid consumption were more prevalent in males. In addition, sex differences influenced physical impairment in ADLs and the number of days they did not feel well. Knowing these aspects will be important.